KWOK-KIN WONG was named chief of hematology and medical oncology at the Perlmutter Cancer Center at NYU Langone Medical Center. Wong will join the Perlmutter faculty in January,. He is a professor of medicine at Harvard Medical School and a clinical oncologist at Dana-Farber Cancer Institute. His research focuses on understanding the pathogenesis and genetic...
New research led by Friends of Cancer Research demonstrates that decreases in circulating tumor DNA after initiation of treatment are associated with improved overall survival in patients with advanced non-small cell lung cancer treated with immunotherapy or chemotherapy.
